Company: IONQ
Filing Date: 2025-08-11
Form Type: 424B7
Source: 0001193125-25-177997
Chunk: 10

Company: IonQ, Inc.
Filing Date: 2025-08-11
Form: 424B7
Chunk 10
---
 — |
| Sylvain Chuard(52)                                                                   |     |                  |       539 |     |            | * |     |              |       539 |     |                             | — |     | — |
| Thomas Camus(53)                                                                     |     |                  |       149 |     |            | * |     |              |       149 |     |                             | — |     | — |
| Thorsten Christiansson(54)                                                           |     |                  |       503 |     |            | * |     |              |       503 |     |                             | — |     | — |
| Universal (Hong Kong) Technology Co.                                                 
 Limited(55)                                                                          |     |                  |    52,453 |     |            | * |     |              |    52,453 |     |                             | — |     | — |
| Université de                                                                        
 Genève(56)                                                                           |     |                  |     9,111 |     |            | * |     |              |     9,111 |     |                             | — |     | — |
| USIT Holdco PC1 LLC(57)                                                              |     |                  | 2,666,660 |     |            | * |     |              | 2,666,660 |     |                             | — |     | — |
| W.A. de Vigier Stiftung(58)                                                          |     |                  |     7,726 |     |            | * |     |              |     7,726 |     |                             | — |     | — |

| * | Less than 1%. |

| (1) | Consists of the maximum number of shares of our common stock being offered pursuant to this prospectus                                                                                                                                               
 supplement by each applicable selling stockholder and, if applicable, any other common stock beneficially owned by such selling stockholder as of August 5, 2025. Includes 902,160 shares of common stock beneficially owned by selling stockholders 
 who received shares of common stock as consideration in our acquisition of a controlling stake of ID Quantique SA that are held in escrow and subject to transfer                                                                                    |

S-9

| (2) | Assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus                                      
 supplement and that the selling stockholders buy or sell no additional shares of our common stock prior to the completion of the offering. |

| (3) | Cons